Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Teratological hip dislocation.

J F Katz

    Israel Journal of Medical Sciences
    |April 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Teratological congenital hip dislocation presents with severe birth deformities due to prolonged development. This complex condition, often linked to various syndromes, poses significant treatment challenges and uncertain outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hydrogen bond integrity between MHC class II molecules and bound peptide determines the intracellular fate of MHC class II molecules.

    Journal of immunology (Baltimore, Md. : 1950)·2001
    Same author

    Energetic asymmetry among hydrogen bonds in MHC class II*peptide complexes.

    Proceedings of the National Academy of Sciences of the United States of America·2001
    Same author

    Metallic fragments on mammography after intraoperative deployment of radiopaque clips.

    AJR. American journal of roentgenology·2000
    Same author

    Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules.

    The Journal of experimental medicine·1996
    Same author

    Invasive aspergillosis involving the thoracic aorta: CT appearance.

    AJR. American journal of roentgenology·1994
    Same author

    T cell receptor recognition of MHC class II alloantigens is highly cell type dependent.

    Journal of immunology (Baltimore, Md. : 1950)·1994
    Same journal

    Coronary revascularization versus conservative medical management for preoperative optimization of a patients with documented ischemic heart disease.

    Israel journal of medical sciences·1998
    Same journal

    Primary biliary cirrhosis--association or overlap with other autoimmune diseases.

    Israel journal of medical sciences·1998
    Same journal

    Complementary medicine--the problem and the challenge.

    Israel journal of medical sciences·1998
    Same journal

    Electroencephalography in the evaluation of headache patients: a review.

    Israel journal of medical sciences·1998
    Same journal

    Complementary medicine--a critical review.

    Israel journal of medical sciences·1998
    Same journal

    The Israel Longitudinal Mortality Study--differential mortality in Israel 1983-1992: objectives, materials, methods and preliminary results.

    Israel journal of medical sciences·1998
    See all related articles

    Area of Science:

    • Orthopedics
    • Developmental Biology
    • Genetics

    Background:

    • Congenital hip dislocation (CHD) encompasses a spectrum of developmental abnormalities of the hip joint.
    • Teratological CHD is characterized by its severe presentation at birth, indicating prolonged intrauterine insult.

    Observation:

    • Advanced severity at birth suggests extended antenatal duration and increased distortion.
    • Etiology may involve multiple, unrelated factors including local intrauterine influences, early embryonic malformations, or genetic disorders.

    Findings:

    • The complex interplay of factors contributes to the severe presentation of teratological CHD.
    • Treatment for this condition is often challenging.

    Implications:

    Related Experiment Videos

  • The uncertain end result necessitates further research into effective management strategies.
  • Understanding the diverse etiologies is crucial for targeted interventions in congenital hip dislocation.